A CASE OF RAPIDLY PROGRESSIVE RETINOPATHY ASSOCIATED WITH PEMBROLIZUMAB IMMUNOTHERAPY FOR METASTATIC UROTHELIAL CARCINOMA.

Daiki SakaiYasuhiko HiramiSunao SugitaAkiko MaedaWataru MatsumiyaMakoto NakamuraYasuo Kurimoto

Published in: Retinal cases & brief reports (2022)

We reported a case of rapidly progressive retinopathy that may have been triggered by pembrolizumab immunotherapy for metastatic urothelial carcinoma. High-dose corticosteroid pulse therapy was effective in reversing photoreceptor damage.

Keyphrases

high dose
multiple sclerosis
squamous cell carcinoma
small cell lung cancer
advanced non small cell lung cancer
low dose
blood pressure
oxidative stress
stem cell transplantation
stem cells
bone marrow
cell therapy